Press Release

« Back

Travere Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results

Feb 16, 2021

SAN DIEGO, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report fourth quarter and full year 2020 financial results on Monday, March 1, 2021 after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.

Conference Call Information

Date:   Monday, March 1, 2021
Time:    4:30 p.m. ET
Dial-in numbers:   +1 (855) 219-9219 (U.S.) or +1 (315) 625-6891 (International)
Confirmation code:   3397951
Live webcast:   Travere.com in the “Events & Presentations” section of the “Investors” page

A replay of the call will be available from 7:30 p.m. ET, March 1, 2021 to 7:30 p.m. ET, March 8, 2021. The replay number is +1 (855) 859-2056 (U.S.) or +1 (404) 537-3406 (International), confirmation code 3397951.

About Travere Therapeutics

At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.

Contact:
Chris Cline, CFA                                 
Senior Vice President, Investor Relations & Corporate Communications
888-969-7879                                        
IR@travere.com


Primary Logo

Source: Travere Therapeutics, Inc.